Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.16
Delayed Data
As of Aug 28
 +0.20 / +10.20%
Today’s Change
1.69
Today|||52-Week Range
5.48
-55.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues32.7M5.0M9.0M5.7M
 
 
 
 
 
Cost of Goods Sold427.0K392.7K1.5M264.9K
 
 
 
 
 
Depreciation And Amortization1.5M1.0M569.4K578.1K
 
 
 
 
 
 
Operating ExpensesGross Income30.8M3.5M6.9M4.8M
 
 
 
 
 
General Expenses29.9M35.1M42.5M51.0M
 
 
 
 
 
Research And Development24.8M29.2M33.1M41.2M
 
 
 
 
 
Total Operating Expenses31.9M36.5M44.6M51.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income874.2K-31.6M-35.6M-46.2M
 
 
 
 
 
Extraordinary Credit0.0016.7M0.000.00
 
 
Interest Expense On Debt0.00----2.1M
 
 
Other Expenses32.0K2.6M938.009.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income906.2K-12.2M-35.5M-48.1M
 
 
 
 
 
Income Taxes-209.8K-44.1K-7.8K-58.2K
 
 
 
 
 
Minority Interest-113.6K-104.8K-105.4K-121.6K
 
 
 
 
 
Net Income810.0K-12.2M-35.4M-48.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.5M78.0M84.6M93.3M
 
 
 
 
 
Shares To Calculate EPS Diluted76.2M78.0M84.6M93.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.01-$0.16-$0.42-$0.51
 
 
 
 
 
EPS Diluted$0.01-$0.16-$0.42-$0.51